Printer Friendly

Enhance reflects limited population.

I treat my patients to goal numbers. The ENHANCE study only shows me that in an unfortunate genetic group, not treating to goal does not result in any benefit ("Next Steps on Ezetimibe, If Any, May Take Months," Feb. 15, 2008, p. 4).

The study does nothing for my average patient except to push me to maximize statin dose and add ezetimibe when goals are not met. I am concerned that so many patients using statins are discouraged by the study and react only to the general information that cholesterol drugs do not work.

Richard Raborn, M.D.

Boynton Beach, Fla.

COPYRIGHT 2008 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Letters
Author:Raborn, Richard
Publication:Family Practice News
Article Type:Letter to the editor
Date:Jun 1, 2008
Words:101
Previous Article:A Doctor's take on legal issues.
Next Article:Challenge of hematologic cancer DX.

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |